3D Bioreactor Fixed Bed for Stem Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 3D bioreactors fail to efficiently scale up stem cell expansion to clinical doses due to limitations in surface area, cell aggregation, phenotype changes, and mechanical stability, while also being costly and prone to contamination.
Innovation Solution
A scalable 3D bioreactor with a fixed bed of biocompatible material featuring non-random interconnected voids and pores, optimized for maximum surface-to-volume ratio, monolayer cell culture, and reduced shear stress, fabricated using additive manufacturing technologies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional 2D planar systems (T-flasks or roller bottles) are used for cell expansion, then cell culture is simple and cost-effective, but the surface area is limited requiring multiple passages and manual handling
Solution Approach 1:
The patent transitions from conventional 2D planar cell culture surfaces to a 3D fixed-bed bioreactor system. The 3D structure provides significantly increased surface area for cell attachment and growth, enabling direct expansion to clinical doses without multiple passages. The fixed-bed configuration with porous particles creates a three-dimensional network that maintains cell monolayers while dramatically increasing productive surface area within a compact volume.
2Reliability
If existing 3D bioreactors are used for cell expansion, then cell aggregation is reduced, but mechanical stability and structural integrity are compromised
Solution Approach 1:
The patent employs a fixed-bed system composed of porous particles with controlled pore sizes and distributions. These porous materials provide mechanically stable structures that maintain structural integrity while offering interconnected pores for medium perfusion and nutrient delivery. The porous architecture prevents cell aggregation by maintaining cell monolayers on particle surfaces while ensuring mechanical stability through the rigid particle framework.
3Productivity
If scale-up is attempted with conventional systems, then production capacity increases, but contamination risk and operational costs increase
Solution Approach 1:
The patent merges multiple functions into a single integrated 3D fixed-bed bioreactor system. The fixed-bed structure combines cell attachment surfaces, medium distribution channels, and cell harvest mechanisms in one unit. This integration eliminates the need for multiple manual operations and transfers between containers, thereby reducing contamination risk while achieving scale-up to clinical production capacities.
4Productivity
If surface area is increased to expand cell capacity, then cell production increases, but shear stress on cells increases causing phenotype changes
Solution Approach 1:
The patent implements local quality control by designing the fixed-bed system with specific pore size distributions and flow path characteristics. The porous particles create localized low-shear zones where cells attach and proliferate, while the overall structure maintains efficient medium flow. This local optimization allows high surface area for cell expansion while protecting cells from excessive shear stress that would cause phenotype changes.
Data Source
Figure 1
Figure 1a~1b
Figure 1c~1d
AI summary
The present disclosure relates to the design, fabrication, and applications of a three-dimensional (3D) bioreactor for cell expansion and cell secreted substance production. The bioreactor is composed of non-random interconnected voids providing a continuous three-dimensional surface area for cell adherence and growth.